Question 1

Does Swiss Life Asset Management own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Swiss Life Asset Management holds 28,220 shares of REGN (Regeneron Pharmaceuticals), worth $17.6M.

Question 2

How many shares of REGN does Swiss Life Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Swiss Life Asset Management holds 28,220 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is Swiss Life Asset Management's REGN position worth?

Accepted Answer

As of its Q2 2026 13F, Swiss Life Asset Management's REGN position is worth $17.6M.

Question 4

Is Swiss Life Asset Management buying or selling REGN?

Accepted Answer

In Q2 2026, Swiss Life Asset Management reduced its REGN position by 2,305 shares (-7.6%).

Question 5

When did Swiss Life Asset Management first buy REGN?

Accepted Answer

Swiss Life Asset Management already held REGN in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	28,220	-7.5%	$17.6M	0.1%	$622.81	0
2026-Q1	Increased	30,525	+183.6%	$14.1M	0.1%	$770.59	45
2025-Q4	Decreased	10,762	-54.5%	$8.3M	0.0%	$768.90	0
2025-Q3	Increased	23,658	+112.0%	$13.3M	0.1%	$559.40	45
2025-Q2	Increased	11,158	+7.3%	$5.9M	0.0%	$521.53	29
2025-Q1	Increased	10,404	+13.4%	$6.6M	0.0%	$629.11	31
2024-Q4	Decreased	9,178	-5.0%	$6.5M	0.0%	$705.67	0
2024-Q3	Increased	9,664	+21.3%	$10.2M	0.1%	$1,041.41	40